Nexus Surgical and Medicare's Stock Price Surges, Outperforms Sector and Sensex.

Jul 12 2024 09:35 AM IST
share
Share Via
Nexus Surgical and Medicare, a microcap company in the finance/NBFC industry, has seen a surge in its stock price, reaching a 52-week high of Rs.19.25 on July 12, 2024. The stock has outperformed the sector by 2.05% and has gained 21.61% in the last 5 days. It is currently trading above its moving averages, indicating a positive trend. In the past year, it has shown a remarkable growth of 90.40%, showcasing its strong performance and potential in the industry. However, this is not a recommendation to buy or sell the stock, but rather a fact-based analysis of its recent performance. Investors are advised to do their own research and consult with a financial advisor before making any investment decisions.

Nexus Surgical and Medicare, a microcap company in the finance/NBFC industry, has recently seen a surge in its stock price. On July 12, 2024, the company's stock reached a 52-week high of Rs.19.25. This has caught the attention of investors and market analysts, with MarketsMOJO giving a 'Sell' call for the stock.

The stock has been performing well, outperforming the sector by 2.05% and gaining for the last 5 consecutive days. In this period, it has seen a significant increase of 21.61% in returns. Additionally, Nexus Surgical is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.

In comparison to the Sensex performance of 22.77%, Nexus Surgical has shown a remarkable 90.40% growth in the past year. This showcases the company's strong performance and potential for growth in the finance/NBFC industry.

Nexus Surgical and Medicare's recent surge in stock price is a reflection of its strong financials and market position. As a microcap company, it has shown impressive growth and has caught the attention of investors. However, it is important to note that this is not a recommendation to buy or sell the stock, but rather a fact-based analysis of its recent performance. Investors are advised to do their own research and consult with a financial advisor before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News